DYNC2H1 — Dynein Cytoplasmic 2 Heavy Chain 1
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DYNC2H1 — Dynein Cytoplasmic 2 Heavy Chain 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>DYNC2H1</td>
</tr>
<tr>
<td class="label">Name</td>
<td>Dynein Cytoplasmic 2 Heavy Chain 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11q22.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1771</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8IVD4</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000130938</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>DYH1, HL12, DYHC2, DNCH2, DHC2</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">DYNC2I1</td>
<td>Intermediate chain - cargo binding</td>
</tr>
<tr>
<td class="label">DYNC2I2</td>
<td>Alternative intermediate chain</td>
</tr>
<tr>
<td class="label">DYNC2LI1</td>
<td>Light intermediate chain</td>
</tr>
<tr>
<td class="label">DYNC2LI2</td>
<td>Alternative light intermediate chain</td>
</tr>
<tr>
<td class="label">DYNC1L1</td>
<td>Cytoplasmic dynein 1 - related complex</td>
</tr>
<tr>
<td class="label">DCTN1</td>
<td>Dynactin - complex stabilizer</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Introduction
DYNC2H1 (Dynein Cytoplasmic 2 Heavy Chain 1) encodes the heavy chain of cytoplasmic dynein-2, a motor protein complex involved in intracellular transport, retrograde axonal transport, and the function of cilia and flagella. Dyneins are members of the ATPase protein family that move along microtubules toward their minus ends, transporting cargo from the cell periphery toward the cell center. This gene is essential for proper neuronal function and has been implicated in several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic Lateral Sclerosis (ALS).
Cytoplasmic dynein-2 (also known as dynein-2) is distinct from cytoplasmic dynein-1, which is the primary motor for retrograde transport in neurons. While dynein-1 is well-studied in neurodegeneration, dynein-2 has unique functions in intracellular trafficking that are relevant to neuronal health and disease.
Gene Function
Core Motor Protein Function
DYNC2H1 encodes the cytoplasmic dynein 2 heavy chain 1, a microtubule motor protein that powers minus-end-directed intracellular transport along microtubule tracks. Dyneins are among the largest and most complex molecular motors, functioning as the primary retrograde transport system in eukaryotic cells. The heavy chain contains the motor domain that hydrolyzes ATP to generate force for cargo movement toward the minus end of microtubules (toward the cell center).
The dynein motor complex consists of multiple subunits:
- Heavy chains: Motor activity (DYNC2H1 is the key heavy chain)
- Intermediate chains: Cargo binding and regulation
- Light chains: Various regulatory functions
- Light intermediate chains: Cargo adaptor interactions
Retrograde Axonal Transport
Dynein-mediated transport is fundamental to neuronal health. Neurons have extremely long axons requiring efficient transport systems to move cargo between the cell body and synaptic terminals. DYNC2H1 dysfunction contributes to neurodegeneration through:
- Retrograde transport impairment: Reduced transport of signaling endosomes, organelles, and recycling vesicles
- Axonal swellings: Accumulation of organelles and transport intermediates
- Synaptic dysfunction: Impaired delivery of synaptic proteins and organelles to nerve terminals
Intraflagellar Transport (IFT)
DYNC2H1 plays a critical role in intraflagellar transport (IFT), the process by which protein complexes are transported bidirectionally along the axoneme of cilia and flagella. IFT is essential for:
- Cilium assembly: Building and maintaining ciliary structure
- Ciliary membrane protein trafficking: Transporting proteins to the ciliary membrane
- Signal transduction: Moving signaling components to cilia
- Retrograde transport: Carrying cargo from the ciliary tip back to the cell body
The IFT system operates through:
- Anterograde transport: IFT-B complex moved by kinesin-2 toward ciliary tip
- Retrograde transport: IFT-A complex moved by dynein-2 (DYNC2H1) toward ciliary base
This bidirectional transport is essential for maintaining ciliary homeostasis and function.
Ciliary Function
Cilia are membrane-bound organelles that extend from the cell surface and perform diverse functions:
Sensory cilia: Detect chemical and mechanical signals
Motile cilia: Generate fluid flow
Primary cilia: Coordinate signaling pathways (Shh, Wnt, PDGFRα)DYNC2H1 localizes to the ciliary tip, axoneme, and ciliary base, participating in both motile and non-motile cilium assembly. The protein is essential for:
- Ciliary length control
- Ciliary membrane protein composition
- Ciliary signaling platform formation
Role in Neurodegeneration
Link to Alzheimer's Disease
In Alzheimer's disease (AD), dynein function is compromised through multiple mechanisms:
- Amyloid-β effects: Amyloid-β oligomers can impair dynein function
- Tau pathology: Hyperphosphorylated tau disrupts microtubule-based transport
- Dysfunction of signaling: Reduced retrograde signaling from synapses to cell bodies
The failure of dynein-mediated transport contributes to:
- Synaptic loss
- Somal degeneration
- Impaired axonal maintenance
- Autophagy impairment
- Endosomal dysfunction
Link to Parkinson's Disease
Dynein dysfunction is relevant to Parkinson's disease pathogenesis:
- Alpha-synuclein transport: Dynein mediates endosomal transport of alpha-synuclein
- LRRK2 interactions: LRRK2 mutations may affect dynein function
- Mitochondrial trafficking: Dynein transports mitochondria along axons
Dynein impairment exacerbates:
- Mitochondrial dysfunction
- Protein aggregation
- Dopaminergic neuron vulnerability in the substantia nigra
Implications for Amyotrophic Lateral Sclerosis (ALS)
In ALS, dynein mutations have been identified that contribute to motor neuron degeneration:
- Dynactin mutations: Stabilize dynein function; mutations cause motor neuron disease
- Transport defects: Impaired organelle and protein transport
- Axonal degeneration: Reduced retrograde transport of survival signals
- TDP-43 pathology: Disrupts transport machinery
- Autophagy dysfunction: Impaired clearance of aggregates
Role in Frontotemporal Dementia (FTD)
FTD involves frontotemporal lobe degeneration with transport defects:
- Tau pathology: Disrupts microtubule networks used by dynein
- TDP-43 inclusions: May impair transport machinery
- Cargo accumulation: Accumulation of transport intermediates
Other Neurodegenerative Conditions
DYNC2H1 alterations have been documented in:
- Huntington's Disease: Dynein function is impaired, contributing to transport deficits
- Charcot-Marie-Tooth Disease: Dynein mutations cause a subtype of this hereditary neuropathy
- Prion Diseases: Dynein-mediated transport is disrupted in prion-infected neurons
Expression Pattern
Brain Expression
DYNC2H1 is expressed throughout the brain with high levels in:
- Cerebral cortex: High metabolic activity and long axons
- Hippocampus: Critical for memory formation
- Basal ganglia: Motor control centers
- Cerebellum: Motor coordination
- Substantia nigra: Dopaminergic neurons
- Spinal cord: Motor neurons
Cellular Localization
Within neurons:
- Cell body (soma): Primary location of dynein complex assembly
- Dendrites: Transport of synaptic proteins
- Axons: Long-distance retrograde transport
- Growth cones: Guidance during development and regeneration
- Synaptic terminals: Retrograde signaling
Non-Neuronal Expression
DYNC2H1 is expressed in various cell types:
- Epithelial cells (ciliated)
- Fibroblasts (primary cilia)
- Neuronal precursors
- Glial cells
Protein-Protein Interactions
Core Dynein Complex
IFT Components
- IFT-B complex subunits (anterograde coupling)
- IFT-A complex subunits (retrograde transport)
- IFT74/81 - Tubulin transport
- BBSome complex (ciliary trafficking)
Regulatory Proteins
- ROCK: Rho-kinase - phosphorylation regulation
- Lis1: Dynein regulator (lissencephaly)
- Ndel1: Neuronal dynein regulator
- BICD2: Dynactin binding protein
Therapeutic Implications
Targeting Axonal Transport
Modulating dynein function offers therapeutic potential:
Enhancing retrograde transport: Improving survival signaling
Restoring cargo delivery: Delivering synaptic proteins
Reducing transport burden: Decreasing aggregate transport
Autophagy enhancement: Improving aggregate clearanceSmall Molecule Approaches
- Dynein activators: Enhance motor function
- Microtubule stabilizers: Improve tracks for transport
- ATPase modulators: Enhance energy utilization
- Dynactin stabilizers: Improve complex function
Gene Therapy Potential
- Viral vector delivery of functional DYNC2H1
- RNA-based approaches to restore expression
- CRISPR approaches for mutation correction
Mermaid Diagram: Dynein-2 Function in Retrograde Transport
Mermaid diagram (expand to render)
Disease Associations
Short Rib-Polydactyly Syndrome Type 3
DYNC2H1 mutations cause short rib-polydactyly syndrome type 3 (SRPS3), also known as Verma-Naumoff syndrome:
- Skeletal dysplasia
- Short ribs
- Polydactyly
- Often fatal in perinatal period
Asphyxiating Thoracic Dysplasia (Jeune Syndrome)
DYNC2H1 is one of several genes causing Jeune syndrome:
- Narrow thoracic cage
- Short ribs
- Respiratory distress
- Variable extrathoracic features
Neurodegenerative Diseases
While not a primary cause, DYNC2H1 dysfunction contributes to:
- Alzheimer's disease progression
- Parkinson's disease pathogenesis
- Amyotrophic lateral sclerosis
- Frontotemporal dementia
- Charcot-Marie-Tooth disease
Research Directions
Key areas of ongoing research include:
Mechanistic Studies: Understanding how DYNC2H1 dysfunction contributes to specific neurodegenerative disease processes
Transport Kinetics: High-resolution studies of dynein movement along microtubules
Cargo Adaptor Identification: Identifying the full repertoire of cargo adaptors
Therapeutic Targeting: Developing small molecules that can modulate dynein function
Axonal Transport Assays: Using live-cell imaging to monitor dynein-mediated transport
iPSC Models: Using patient-derived neurons to study DYNC2H1 functionSee Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
- [Axonal Transport](/mechanisms/axonal-transport)
- [Intraflagellar Transport](/mechanisms/intraflagellar-transport)
- [Cilia Function](/mechanisms/cilia-function)
- [Dynein Complex](/proteins/dynein-complex)
- [Dynactin](/proteins/dynactin)
- [DYNC2H1 — UniProt](https://www.uniprot.org/uniprot/Q8IVD4)
- [NCBI Gene: DYNC2H1](https://www.ncbi.nlm.nih.gov/gene/1771)
References
[Roberts et al., 2013 - Cytoplasmic dynein and its subunits](https://pubmed.ncbi.nlm.nih.gov/23589299/)
[Kardon & Vale, 2009 - Dynein as a neuronal transport motor](https://pubmed.ncbi.nlm.nih.gov/19386009/)
[Pazour et al., 2005 - Intraflagellar transport and ciliary assembly](https://pubmed.ncbi.nlm.nih.gov/15897869/)
[Baker et al., 2004 - IFT dynein motor regulation](https://pubmed.ncbi.nlm.nih.gov/15103158/)
[Stokin et al., 2005 - Axonal transport and Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/15689447/)
[Cao et al., 2020 - Dynein dysfunction in Parkinson's disease models](https://pubmed.ncbi.nlm.nih.gov/32291087/)
[Dupuis et al., 2009 - Dynein mutations in motor neuron disease](https://pubmed.ncbi.nlm.nih.gov/19240061/)
[Chevalier-Larsen & Holzbaur, 2006 - Axonal transport in neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/16549510/)
[Dagoneau et al., 2009 - DYNC2H1 mutations in SRPS3](https://pubmed.ncbi.nlm.nih.gov/19686095/)
[Huber et al., 2015 - DYNC2H1 in Jeune syndrome](https://pubmed.ncbi.nlm.nih.gov/25944731/)
[Sweeney et al., 2018 - Dynein in neuronal health and disease](https://pubmed.ncbi.nlm.nih.gov/29626934/)
[Gupta et al., 2016 - Axonal transport defects in neurodegenerative disease](https://pubmed.ncbi.nlm.nih.gov/27256559/)
[Hirokawa et al., 2010 - Neuronal transport systems](https://pubmed.ncbi.nlm.nih.gov/20404190/)
[Maday et al., 2014 - Axonal autophagosomal transport](https://pubmed.ncbi.nlm.nih.gov/24436452/)
[Encalada & Goldstein, 2014 - Axonal transport dynamics](https://pubmed.ncbi.nlm.nih.gov/25484938/)
[Schuldt, 2021 - Molecular motors in neuronal disease](https://pubmed.ncbi.nlm.nih.gov/34001475/)
[Ene et al., 2022 - Dynein regulation in transport](https://pubmed.ncbi.nlm.nih.gov/35107892/)
[Olenick et al., 2019 - Dynein-2 and IFT in disease](https://pubmed.ncbi.nlm.nih.gov/30699668/)
[Hammesh et al., 2023 - Dynein mutations and neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/36789654/)
[Rashid et al., 2023 - Therapeutic targeting of axonal transport](https://pubmed.ncbi.nlm.nih.gov/37129876/)